Kimberly G Yen, Mohamed A Hussein. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralAdrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/adverse effectsEyelid Neoplasms/drug therapyHemangioma, Capillary/drug therapyHumansInfantPropranolol/administration & dosagePropranolol/adverse effects
Substances： See more » Adrenergic beta-AntagonistsPropranolol
Year: 2013 PMID： 23751438 DOI： 10.1097/IIO.0b013e31828b7b97
Source DB: PubMed Journal: Int Ophthalmol Clin ISSN： 0020-8167